Tempus AI Inc (TEM) Stock AnalysisTEMTempus AI Inc

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. It operates in the Healthcare sector.

Tempus AI Inc is a good buy right now due to its current price of $67.615, which is below the average analyst price target of $80 to $95, indicating significant upside potential. Additionally, the company reported a gross margin of 64.45% in Q2 2026, showing strong profitability potential despite recent losses. However, the main risk is the high short interest of 29.17%, indicating potential volatility if sentiment shifts.